Loading...
PPARs: Protectors or Opponents of Myocardial Function?
Pol, Christine J. Lieu, Melissa
Pol, Christine J.
Lieu, Melissa
Citations
Altmetric:
Genre
Journal article
Date
2015-12-02
Advisor
Committee member
Department
Pharmacology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1155/2015/835985
Abstract
Over 5 million people in the United States suffer from the complications of heart failure (HF), which is a rapidly expanding health complication. Disorders that contribute to HF include ischemic cardiac disease, cardiomyopathies, and hypertension. Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family. There are three PPAR isoforms: PPARα, PPARγ, and PPARδ. They can be activated by endogenous ligands, such as fatty acids, as well as by pharmacologic agents. Activators of PPARs are used for treating several metabolic complications, such as diabetes and hyperlipidemia that are directly or indirectly associated with HF. However, some of these drugs have adverse effects that compromise cardiac function. This review article aims to summarize the current basic and clinical research findings of the beneficial or detrimental effects of PPAR biology on myocardial function.
Description
Citation
Christine J. Pol, Melissa Lieu, Konstantinos Drosatos, "PPARs: Protectors or Opponents of Myocardial Function?", PPAR Research, vol. 2015, Article ID 835985, 19 pages, 2015. https://doi.org/10.1155/2015/835985
Citation to related work
Hindawi
Has part
PPAR Research, Vol. 2015
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu